Candesartan cilexetil 16 MG TB 90S
Ended Awarded
- Contract number
- SPE2DB26FTXW8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $30,011
Award facts
- Contract value 100% obligated
- $30,011.03 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $30,011.03 firm fixed price delivery order to AmerisourceBergen Drug Corp on October 16, 2025, for the supply of Candesartan Cilexetil 16 mg tablets (90-count units). This non-set-aside competitive award is scheduled for completion by October 17, 2025, with performance executed from the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a significant role as a critical federal medical procurement vendor. The company supplies a broad portfolio of pharmaceutical products and medical supplies to support military and veteran healthcare systems, including brand-name and generic medications across multiple therapeutic domains. This Candesartan Cilexetil delivery order exemplifies the ongoing pharmaceutical procurement needs of the Defense Health Agency and other government healthcare systems through DLA's Troop Support Medical supply chain. The firm fixed price structure and rapid completion timeline reflect the routine nature of pharmaceutical replenishment orders within the broader federal medical logistics framework.
Quick answers
Who was awarded contract SPE2DB26FTXW8?
SPE2DB26FTXW8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 16, 2025.
How much is contract SPE2DB26FTXW8 worth?
The government has obligated $30,011 on SPE2DB26FTXW8.
Is contract SPE2DB26FTXW8 an order under another contract?
Yes. SPE2DB26FTXW8 is a delivery order under SPE2DB22D1041, an indefinite delivery contract.
Was contract SPE2DB26FTXW8 competed?
The extent of competition for SPE2DB26FTXW8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award